Answers are grounded in this paper and cite their sources.
This research demonstrates enhanced thermostability and catalytic efficiency in GH10 xylanase, suggesting improved xos yield.
Rational design was performed to enhance the thermostability and catalytic efficiency of a GH family 10 xylanase (PaXyn10A) from Paecilomyces aerugineus. By identification of flexible regions and avoidance of functionally conflicting sites via molecular dynamics simulations and sequence alignment, the mutant PaXyn10A D68F/S95A was obtained. The optimum temperature of PaXyn10AD68F/S95A was increased by 5 °C, and the thermal inactivation half-lives at 50 °C was increased by 11.5 times when compared to that of PaXyn10A. Meanwhile, PaXyn10AD68F/S95A showed a 2.1-fold increase in specific activity as well as a 3.9-fold increase in catalytic efficiency. Under optimal conditions, an XOS yield of 64.27% from corn stover was obtained via the combination of PaXyn10AD68F/S95A hydrolysis and steam explosion. These findings demonstrate that computational-simulation-guided rigidification of flexible regions via rational point mutagenesis is an effective strategy to enhance both the thermostability and catalytic efficiency of GH10 xylanases.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: